Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Skin Neoplasms 1Melanoma 1Colonic Neoplasms 1Carcinoma, Basal Cell 1

Interventions

pembrolizumab 2smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1prednylidene 1methyl 5-aminolevulinate 1gusacitinib 1deltacortene 1Specimen Handling 1Sirolimus 1Prednisone 1Photochemotherapy 1Nivolumab 1Methods 1Magnetic Resonance Spectroscopy 1MAPRE1 protein, human 1Ipilimumab 1Interleukin-2 1HhAntag691 1CTLA-4 Antigen 1Biopsy 1BF-200 ALA 1Arsenic Trioxide 1Aminolevulinic Acid 15-aminolevulinic acid hexyl ester 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Carcinoma, Basal Cell × Methods × Clear all
NCT00403377 2015-10-01

Investigation of a Behavioral Substitute for Sunbathing

University of Massachusetts, Worcester

Phase 1/2 Completed
307 enrolled
Dermatologic

Carcinoma, Basal Cell, Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡